Provided by Tiger Trade Technology Pte. Ltd.

Harmony Biosciences Holdings, Inc.

36.01
+0.16000.45%
Post-market: 36.790.7800+2.17%18:37 EST
Volume:585.22K
Turnover:21.26M
Market Cap:2.07B
PE:11.37
High:36.95
Open:36.40
Low:35.97
Close:35.85
52wk High:40.87
52wk Low:25.52
Shares:57.60M
Float Shares:44.56M
Volume Ratio:1.11
T/O Rate:1.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.17
EPS(LYR):2.51
ROE:25.93%
ROA:13.20%
PB:2.48
PE(LYR):14.35

Loading ...

Harmony Biosciences Cut to Neutral From Buy by UBS

Dow Jones
·
Feb 11

Harmony Biosciences Holdings Inc. to Report Fourth Quarter and Full Year 2025 Financial Results

Reuters
·
Feb 10

Harmony Biosciences CFO Sandip Kapadia Reports Disposal of Common Shares

Reuters
·
Jan 29

Harmony Biosciences CFO Sandip Kapadia Reports Disposal of Common Shares

Reuters
·
Jan 21

Harmony Biosciences : Needham Raises Target Price to $46 From $42

THOMSON REUTERS
·
Jan 20

Harmony Biosciences Holdings (HRMY) Receives a Buy from H.C. Wainwright

TIPRANKS
·
Jan 13

BRIEF-Harmony Biosciences Guides To Over $1 Billion In Wakix® Revenue In 2026 Advancing Robust Late-Stage Pipeline With Potential For Long-Term Value Creation

Reuters
·
Jan 12

Harmony Biosciences Q4 Prelim Unaudited Net Product Revenue $243 Mln

THOMSON REUTERS
·
Jan 12

Harmony Biosciences: Wakix Net Revenue Projected Between $1.0 Bln - $1.04 Bln for 2026

THOMSON REUTERS
·
Jan 12

Harmony Biosciences Projects WAKIX Revenue to Surpass $1 Billion in 2026

Reuters
·
Jan 12

Harmony Biosciences Is Maintained at Buy by Truist Securities

Dow Jones
·
Jan 09

Harmony Biosciences price target lowered to $45 from $48 at Truist

TIPRANKS
·
Jan 08

Harmony Biosciences to Present at J.P. Morgan Healthcare Conference

Reuters
·
Jan 07

Jeffrey M. Dayno, President and CEO, Reports Disposal of Harmony Biosciences Holdings Inc. Common Shares

Reuters
·
Dec 18, 2025

BRIEF-Beacon Biosignals Announces Partnership With Harmony Biosciences

Reuters
·
Dec 16, 2025

Harmony Biosciences Partners with Beacon Biosignals to Advance EEG-Based Sleep Disorder Trials

Reuters
·
Dec 16, 2025

Beacon Biosignals Announces Partnership With Harmony Biosciences to Advance Objective Clinical Endpoints in Hypersomnia Conditions Through Quantitative Eeg

THOMSON REUTERS
·
Dec 16, 2025

Harmony Biosciences CFO Sandip Kapadia Reports Disposal of Common Shares

Reuters
·
Dec 10, 2025

Harmony Biosciences Reports Promising Phase 3 Data for EPX-100 in Dravet Syndrome

Reuters
·
Dec 08, 2025

Harmony Biosciences (HRMY) Is Up 7.6% After GR Pitolisant Bioequivalence Win and Patent Runway Push

Simply Wall St.
·
Dec 05, 2025